INTRODUCTION
============

The major problems of obesity are the associated comorbidities, such as hypertension, type 2 diabetes mellitus, cardiovascular diseases, alterations in the lipid profile and muscle skeletal disorders^[@r16]^.

Surgical treatment is the most efficient way to control morbid obesity^[@r23]^, because it makes possible to lose a big amount of weight and preserve the low weight^[@r17]^. The Roux-en-Y Gastric Bypass (RYGB) is the most performed operation in Brazil, and from the several techniques and procedures, it corresponds to more than 80%; even though, the procedures using adjustable gastric bands are becoming more common^[@r02]^. Due to the increase in the number of bariatric surgeries, the complications have become more evident in the last years. From these, the deficiency of albumin, ferritin, vitamins and micronutrients must be detached.

There are many ways to evaluate results, among them the BAROS and the Moorhead-Ardelt quality of life questionnaire II, which is also included in BAROS^[@r10],[@r13],[@r14],[@r15],[@r19],[@r22]^.

It is noticeable that there are not many publications in the literature discussing the association between nutritional disorders and quality of life with weight loss^[@r05],[@r08],[@r21]^. So, this study aims to investigate the nutritional disorders in patients submitted to bariatric surgeries and its connections with weight loss and quality of life.

METHODS
=======

This study was approved by the Ethical Committee Research under the registration 12.243.4.01III. Data were obtained after the concordance of all the patients, by signing a Consent Term, in which they accepted to participate of this study, and all of them were 18 years old or older.

It is a prospective cohort study, performed with patients who were submitted to a surgery for obesity in the Digestive Tract Surgery Department of Nossa Senhora da Conceição Hospital, Tubarão, SC, Brazil, from July 2012 to December 2012.

The surgical technique of RYGB was performed with a proximal stomach pouch measuring 4 cm in the small curvature in which was possible to fit 70 ml, calibrated with a Fouchet 34 catheter and the anastomoses was calibrated with 12 mm. The gastric limb measured around 80 cm and the biliopancretic 100 cm; the food flow of the intestine was anastomosed to the stomach by pre-colonic via. Both were mechanic anastomoses done with a linear stapler, with reinforcement by two continuous suture lines with polidioxanona 3.0 thread. Routinely the mesenteric openings were shutdown when performed.

The post-operatory reviews were done in one, three and six months after the surgery and then they were scheduled according to the clinical necessity; however, they varied on each four months.

During the postoperative period, all the patients used multivitamin twice daily. As for vitamin D contents, patients have started to take it with level minor than 30 pmol/l to get their parathyroid hormone serum levels under 35 pg/ml. The treatment to the decrease of B12 vitamin started when patients\' levels were minor than 350 pg/ml, it was done by an intramuscular B complex injection once a month. All these recommendations were based on the Endocrine Society Guide, which gives directions to follow the patients and to handle their nutritional disorders after the bariatric surgeries^[@r09]^. One patient would be considered anemic when its hemoglobin was under 12,8 g/dl.

Data collection were divided in three periods: perioperative, at the third, and at the sixth months after the operation.

In the perioperative period, before the surgery, the following data were collected: age, gender, weight, BMI, comorbidities, medications in use, answer of the Moorehead-Ardelt II quality of life questionnaire; also were collected details of surgical procedure: surgery information, hospitalization time, surgery time, any operation associated, type of gastroplasty, perioperative complications and re-operations.

In the third month after the surgery, were documented the B12 vitamin levels, total serum proteins and its fractions, ferritin and the patients were submitted to the BAROS.

At the end of the sixth month were collected: total proteins and its fractions, B12 vitamin and a new BAROS.

For the results, patients were classified in five groups: failure, flaw, good, very good, excellent.

Data analysis
-------------

Data were typed in the software Epinfo 3.5.3 and analyzed in the software SPSS v.20.0. The variables were described by Mean and Standard Deviation to the quantitative variations and absolute and relative frequencies to the qualitative variables. The statistical tests were the chi-square or the T test according to the need. The significance level adopted was 95%.

RESULTS
=======

Were operated 67 patients, but eight were excluded according to exclusion criteria; so, were enroll 59 in final account. From these, 47 (79,7%) were women, 43 (72,9%) were married at the moment of data collection and there was a mean of age of 37,8 years old.

Major of obese in the preoperative period had BMI between 40 to 49,9 kg/m^2^, as shown in [Table 1](#t01){ref-type="table"}. It has also been demonstrated that the mean of weight excess among men was significantly bigger than among women.

###### 

Sample distribution according to gender, BMI and mean of %WE

  BMI          Men                  Women                Total
  ------------ -------------------- -------------------- --------------------
  35 to 39,9   2 / 16,7% / 164,2    20 / 42,6% / 167,9   22 / 37,3% / 167,6
  40 to 49,9   8 / 66,7% / 196      25 / 53,2% / 192,7   33 /55,9% / 193
  50 to 59,9   2 / 16,7% / 250,8    2 / 4,3% / 236,4     4 /6,8% / 243
  Total        12 / 20,3% / 199,9   47 / 79,7% / 184     59 / 100% / 187,3

Legend: % WE=percentage of weight excess

Forty individuals had any kind of comorbidities in the preoperative interview. [Table 2](#t02){ref-type="table"} shows that diabetes mellitus was totally solved in 77,8% of the patients after six months, it also demonstrates the degree of resolution of other comorbidities.

###### 

Degree of resolution of comorbidities (n/%)

                                    Total     Not resolved   Partly resolved   Fully resolved                        
  --------------------------------- --------- -------------- ----------------- ---------------- --------- ---------- ---------
  Diabetes mellitus                 9/22,5%   \-             \-                3/33,3%          2/22,2%   6/66,7%    7/77,8%
  Hipertension                      26/65%    3/11,5%        1/3,8%            6/23,1%          6/23,1%   17/65,4%   19/73,1
  Dyslipidemia                      10/25%    \-             \-                \-               \-        10/25%     10/25%
  Sleep apnea                       4/10%     \-             \-                3/75%            1/25%     1/25%      3/75%
  Arthrosis                         7/17,5%   \-             \-                3/43%            3/43%     4/57%      4/57%
  Lower extremities venous stasis   1/2,5%    \-             \-                1/100%           1/100%    \-         \-
  Reflux disease                    7/17,5%   2/29%          2/29%             2/29%            \-        3/43%      5/71,4%

[Table 3](#t03){ref-type="table"} shows the scores obtained in the Moorhead-Ardelt II Quality of Life questionnaire, discriminating the six different issues. Scores were all progressively bigger in the two postoperative moments, comparing to the preoperative ones. In the sixth month, all the issues\' scores were significantly bigger when comparing to the preoperative period (p\<0,05).

###### 

Quality of life distribution in the pre and postoperative periods according to the Moorehead-Ardelt II questionnaire

  Quality of life     Variation    Pre-op mean (SD[\*](#TFN01){ref-type="table-fn"})   3^rd^ month mean (SD)   6^th^ month mean (SD)   Difference 6^th^ M-- Pre-op   p
  ------------------- ------------ --------------------------------------------------- ----------------------- ----------------------- ----------------------------- ------
  Self-esteem         -0,5 a 0,5   0,11 (±0,28)                                        0,41(±0,11)             0,43(±0,10)             0,32                          0,00
  Physical activity   -0,5 a 0,5   -0,05(±0,31)                                        0,17(±0,26)             0,24(±0,23)             0,29                          0,00
  Social contacts     -0,5 a 0,5   0,22(±0,25)                                         0,41(±0,12)             0,42(±0,13)             0,20                          0,00
  Work                -0,5 a 0,5   0,19(±0,28)                                         0,39(±0,14)             0,42(±0,13)             0,23                          0,00
  Sexual activity     -0,5 a 0,5   0,13(±0,32)                                         0,31(±0,26)             0,33(±0,25)             0,20                          0,00
  Food                -0,5 a 0,5   0,04(±0,23)                                         0,38(±0,14)             0,42(±0,10)             0,38                          0,00
  Total               -3 a 3       0,66                                                2,1                     2,28                    1,62                          0,00

SD=standard deviation

Fifteen patients (25,4%) had lost 50% or more of their weight excess by the end of the third month and 50 (85,7%) by the end of the sixth month. Also, by the end of the sixth month 27 (67,5%) had all the major comorbidities considered resolved ([Table 4](#t04){ref-type="table"}).

###### 

Patient distribution according to their punctuation at BAROS system in the third and sixth months after the surgery

                                                         3^rd^ month   6^th^ month        
  ------------------------------------------------------ ------------- ------------- ---- ------
  Weight gain (-1)[\*](#TFN02){ref-type="table-fn"}      \-                          \-    
  0-24 (0)[\*](#TFN02){ref-type="table-fn"}              1             1,7           \-    
  25-49 (1)[\*](#TFN02){ref-type="table-fn"}             43            72,9          9    15,3
  50-74 (2)[\*](#TFN02){ref-type="table-fn"}             15            25,4          43   72,9
  75-100 (3)[\*](#TFN02){ref-type="table-fn"}            \-                          7    11,9
  Total                                                  59                          59    
  II\. Comorbidities control                                                               
  Aggravated (-1)[\*](#TFN02){ref-type="table-fn"}       0             0             0    0
  Unchanged (0)[\*](#TFN02){ref-type="table-fn"}         5             12,5          3    7,5
  Improved (1)[\*](#TFN02){ref-type="table-fn"}          7             17,5          5    12,5
  One \> resolved (2)[\*](#TFN02){ref-type="table-fn"}   8             20            5    12,5
  All \> resolved (3)[\*](#TFN02){ref-type="table-fn"}   20            50            27   67,5
  No comorbidities                                       19                          19    
  Total                                                  59                                

These values correspond to the punctuation received according to the BAROS system

[Figure 1](#f01){ref-type="fig"} shows that the BAROS final concept had a progressive improve when comparing the third and the sixth months; in the third, 33 patients (55,9%) presented a very good or excellent concept; and by the end of the sixth month, 48 patients (81,3%) presented the same concept.

![BAROS score distribution according to the patient numbers](abcd-28-01-0048-g01){#f01}

Only one patient filled criteria for immediate postoperative complications, because of dehiscence and deep venous thrombosis. This same individual was the only one who needed to go over a second surgery.

[Table 5](#t05){ref-type="table"} clarifies the prevalence of nutritional disorders; it is noticed that the vitamin D deficiency by the end of the third month occurred in three patients (5,1%); by the end of the sixth month there were 9 (15,3%) patients in this situation. The protein deficiency was the same in both periods evaluated. B12 vitamin deficiency was bigger in the third month after the surgery (5,1%) when comparing to the sixth month (1,7%). Calcium deficiency was present in 3,4% and 5,1% respectively in the third and sixth month after the surgery. Anemia was present in 6,8% of patients three months after and 13,6% in six months. It has not been evidenced ferritin deficiency.

###### 

Nutritional disorders prevalence

  Deficiency     3^rd^ month postoperative   6^th^ month postoperative
  -------------- --------------------------- ---------------------------
  Proteins       6 / 10,2 %                  6 / 10,2%
  B 12 Vitamin   3 / 5,1%                    1 / 1,7%
  Ferritin       0                           0
  D Vitamin      3 / 5,1%                    9 / 15,3%
  Calcium        2 / 3,4%                    3 / 5,1%
  Anemia         4 / 6,8%                    8 / 13,6%

[Table 6](#t06){ref-type="table"} shows that there was no significant difference in the overweight loss percentage (%OL) among patients with or without a nutritional disorder; it also demonstrates that the quality of life score in patients with a nutritional disorder improves from the third to the sixth month and it does not change among patients without a nutritional disorder. In the third month after the surgery, 16 patients presented any kind of nutritional disorder and 43 did not. At the end of the six months, 23 patients had any nutritional disorder and 36 did not.

###### 

Overweight loss percentage and quality of life analysis relating to the presence of nutritional disorders in the third and sixth months after the surgery

                   3^rd^ month    6^th^ Month                                         
  ---------------- -------------- -------------- ------ -------------- -------------- ------
  %OLP (mean/SD)   42,9 (±10,9)   43,9 (±8,01)   0,70   60,9 (±10,6)   61,9 (±13,2)   0,77
  QoL (mean/SD)    1,8 (±0,92)    2,21 (±0,71)   0,12   2,41 (±0,71)   2,21 (±0,53)   0,21

ND=nutritional disorder; SD=standard deviation; QoL=quality of life - Morehead Ardel II questionnaire

DISCUSSION
==========

This study has been limited to the presence of some nutritional parameters among patients submitted to gastroplasty. It has not aimed an extensive and detailed analysis of micro and macronutrients of an individuals\' diet.

As it is observed in the national and international studies, there was a significant higher prevalence among women. A North-American study involving 700 patients submitted to the RYGB had a female prevalence of 82%. Studies have demonstrated that in Brazil the female prevalence is between 71-80%^[@r01],[@r04]^. In this study the female prevalence was 72,9%. However, the obesity prevalence among Brazilian population, according to the Brazilian Society of Bariatric and Metabolic Surgery was estimated in 18% among women and in 13% among men^[@r24]^. Even though obesity is more frequent among women than among men, this difference is not so significant when comparing with the operated patients. These evidences show that the search for a surgical treatment of obesity is higher among women then among men^[@r18]^.

About age, this study has been very close to most of the studies available in the literature. In this research, the mean of age was 37,8 years old. As the Brazilian Society of Bariatric and Metabolic Surgery shows, when sum the overweight and obese patients it is noticeable that most of them is between 18-25 years old, different of the mean of age that generally the patients submit to the surgery. Other studies have demonstrated similar data, possibly representing a late search for the surgical treatment, after frustrated tries of losing weight by clinical methods^[@r03],[@r06],[@r24]^.

In this study, it has been demonstrated that 55,9% of patients had preoperative BMI between 40-49,9 kg/m^2^, agreeing with the study by Blume *et al*.^[@r03]^ in which the mean of BMI was 48,8 kg/m^2^ and with another research that obtained a mean of 45,2 kg/m^2^. Most of obese who are submitted to the operation, follow the formal indications: BMI bigger or equal to 40 kg/m^2^or BMI between 35-39,9 kg/m^2^ associated to one comorbidity^[@r03],[@r11],[@r25]^.

An important factor to be evaluated is the overweight loss percentage after the operation. Welch *et al.* ^[@r26]^ related that after two years and a half, the patients presented a %OL of 59,1%; also, 70,8% had lost at least 50% of their overweight. Other studies, also following patients for two years demonstrated that the biggest mean of %OL was at the 18^th^ month, with a value of 75,3% and 73,2%^[@r01],[@r26]^. Brazilian studies have showed that six months after the RYGB the mean of %OL was 58,3%^[@r03],[@r25]^. In this study, by the end of six months, 84,7% had lost 50% or more of their overweight. According to the current recommendations, it is considered surgery success when there is a %OL bigger than 50% after the surgery. It is observed that the overweight loss of this research\'s patients has been above average and occurred earlier when comparing to the literature.

About comrbodities, Blume *et al.* ^[@r03]^ demonstrated the presence of diabetes mellitus in 14,7% in the preoperative period and only 1,8% still had that disorder six months after the surgery; in another study, 19% of obese presented it before the surgery and 83% solved this comorbidity after the surgery^[@r03],[@r07]^. About hypertension, 45% of patients had this disease before the surgery, but 87% of them demonstrated to be healed from it after the surgery^[@r03],[@r07]^. Aforementioned data are close to the values found by this study, demonstrating that the obesity surgery improves the patients from the most prevalent comorbidities.

BAROS is very useful advice to global evaluate the results of the obesity surgery, because it evaluates plenty factors. Prazeres *et al.* ^[@r18]^ in their study involving 66 patients showed that in the period between six and eighteen months, 67% of the patients presented a \"good\" score. In another study involving 684 patients, after six months, 50% of presented a \"good\" score and 32% \"very good\". Prevedello *et al.* ^[@r19]^showed that the end thirty months 21,9% of the patients had an \"excellent\" score and 50% \"very good\"^[@r18],[@r19]^. In this research, 81,3% of the operated patients already presented a score \"very good\" or \"excellent\" six months after the surgery and only one patient presented a \"weak\" score. This result is very satisfactory when compared to recent publications, even more for knowing about the importance of BAROS as an advice to evaluate the result^[@r01],[@r18],[@r19]^.

About the nutritional disorders, there are plenty variations on talking about the deficiencies in the pre and postoperative periods. Moizé *et al.* ^[@r12]^, in their research involving 231 patients, estimated that the protein and albumin deficiencies in the preoperative period was around 1,6% among the patients, the ferritin deficiency in 10,3% of the patients, B12 vitamin in 2,2%, D vitamin in 67,7% and anemia in 22,2% of the patients. It contrasts to Ems *et al.* ^[@r06]^ who demonstrated that the albumin deficiency in the preoperative period is in 12,5% of the patients, ferritin in 6,9%, B12 vitamin in 18,1%, D vitamin in 25,4% and anemia in 6,9% during the preoperative period^[@r06],[@r12]^. This study did not aim to quantify the nutritional disorder in the preoperative period, even though some patients probably already had them and they may have been kept after the surgery for some reasons not related to the surgical procedure.

When talking about nutritional complications in the postoperative period it is noticed a change about its prevalence. After six months, a Brazilian study has showed that the albumin deficiency is present in 0,6% of the patients, ferritin in 4,1%, anemia in 21,8% and B12 vitamin deficiency in 3,5%^[@r03]^. In another study, after one year, 4% of patients presented albumin deficiency, 15% ferritin, 30% D vitamin and 11% B12 vitamin^[@r25]^. To prove the big variation of nutritional disorders in the postoperative period, a North-American revision study published in 2013 pointed that the prevalence of B12 vitamin deficiency varies from 4-62% and the D vitamin deficiency prevalence goes from 7-60%^[@r20]^. In this study, it has not been evidenced ferritin deficiency; only 1,7% of the patient presented B12 vitamin deficiency and 13,6% had anemia. All the values cited were measured six months after the surgery. It is worth to detach that there was a low prevalence of nutritional disorders in the postoperative period of this sample when comparing to other national and international studies.

It is noticeable that there is no patron in the literature about nutritional deficiency in pre and postoperative periods. It was usual to deduce that with the surgery and the functional anatomic alteration - with a potential absorptive deficit in the gastrointestinal tract -, most of the nutritional deficiencies would be present in the postoperative period. However, this thought has not been proved by the literature and it has been evidenced that many patients when go through the surgery already have some kind of deficiency. The most important thing to notice is that there was no significant difference of %OL neither of quality of life between the patients with a nutritional disorder and those who did not present these deficiencies. This data disagrees with the sentence: as bigger the weight loss, bigger the nutritional disorder and that the nutritional deficiencies could be related to a worse quality of life^[@r18]^.

CONCLUSION
==========

Nutritional disorders are not frequent in early postoperative period of RYGB. When present, they are shortly or not related to patients\' quality of life and overweight loss.
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